Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction

Detalhes bibliográficos
Autor(a) principal: Goncalves, Andrey C. da Costa
Data de Publicação: 2009
Outros Autores: Tank, Jens, Diedrich, Andre, Hilzendeger, Aline Mourão [UNIFESP], Plehm, Ralph, Bader, Michael [UNIFESP], Luft, Friedrich C., Jordan, Jens, Gross, Volkmar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.124776
http://repositorio.unifesp.br/handle/11600/31271
Resumo: Leptin receptor-deficient db/db mice develop human type 2 diabetes mellitus, hypertension, and obesity with disrupted circadian blood pressure (BP) rhythm. Whether leptin is the sole mechanism mediating autonomic imbalance and hypertension is unclear. To explore this notion further, we measured BP by radiotelemetry combined with fast Fourier transformation and assessed autonomic function pharmacologically before and after renin-angiotensin system blockade with enalapril. the resting period BP (117 +/- 3 versus 108 +/- 1.0 mm Hg) and heart rate (HR; 488 +/- 12 versus 436 +/- 8 bpm) were higher in db/db mice compared with db/+ mice. BP and HR amplitudes were lower in db/db mice compared with db/+ mice. BP response to trimetaphan (-43 +/- 5 versus -27 +/- 3 mm Hg) and HR response to metoprolol (-59 +/- 12 versus -5 +/- 4 bpm) were greater in db/db mice than in db/+ mice. the HR response to atropine was blunted in db/db mice (59 +/- 17 versus 144 +/- 24 bpm), as were baroreflex sensitivity and HR variability. Enalapril improved autonomic regulation in db/db mice. Stimulation of central alpha-2 adrenoreceptors enhanced both parasympathetic HR control and baroreflex sensitivity in db/db mice. We suggest that functional, rather than structural, alpha-2 adrenoceptor changes and the renin-angiotensin system are involved in the increased sympathetic and decreased parasympathetic tones in db/db mice. Our data suggest that db/db mice exhibit features found in humans with type 2 diabetic autonomic neuropathy and could serve as a model for this complication. (Hypertension. 2009; 53[part 2]: 387-392.)
id UFSP_f490f6386c7be90cfabf1bf734b9afc1
oai_identifier_str oai:repositorio.unifesp.br/:11600/31271
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunctiontype 2 diabetes mellitusobesityhypertensionACE inhibitionalpha-2 adrenoceptorsautonomic dysfunctionLeptin receptor-deficient db/db mice develop human type 2 diabetes mellitus, hypertension, and obesity with disrupted circadian blood pressure (BP) rhythm. Whether leptin is the sole mechanism mediating autonomic imbalance and hypertension is unclear. To explore this notion further, we measured BP by radiotelemetry combined with fast Fourier transformation and assessed autonomic function pharmacologically before and after renin-angiotensin system blockade with enalapril. the resting period BP (117 +/- 3 versus 108 +/- 1.0 mm Hg) and heart rate (HR; 488 +/- 12 versus 436 +/- 8 bpm) were higher in db/db mice compared with db/+ mice. BP and HR amplitudes were lower in db/db mice compared with db/+ mice. BP response to trimetaphan (-43 +/- 5 versus -27 +/- 3 mm Hg) and HR response to metoprolol (-59 +/- 12 versus -5 +/- 4 bpm) were greater in db/db mice than in db/+ mice. the HR response to atropine was blunted in db/db mice (59 +/- 17 versus 144 +/- 24 bpm), as were baroreflex sensitivity and HR variability. Enalapril improved autonomic regulation in db/db mice. Stimulation of central alpha-2 adrenoreceptors enhanced both parasympathetic HR control and baroreflex sensitivity in db/db mice. We suggest that functional, rather than structural, alpha-2 adrenoceptor changes and the renin-angiotensin system are involved in the increased sympathetic and decreased parasympathetic tones in db/db mice. Our data suggest that db/db mice exhibit features found in humans with type 2 diabetic autonomic neuropathy and could serve as a model for this complication. (Hypertension. 2009; 53[part 2]: 387-392.)Max Delbruck Ctr Mol Med, D-13125 Berlin, GermanyHannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, GermanyUniversidade Federal de São Paulo, Dept Biophys, Escola Paulista Med, São Paulo, BrazilVanderbilt Univ, Sch Med, Dept Med, Auton Dysfunct Serv,Div Clin Pharmacol, Nashville, TN 37212 USAHELIOS Klin, Franz Volhard Clin, Fac Med Charite, Berlin, GermanyUniversidade Federal de São Paulo, Dept Biophys, Escola Paulista Med, São Paulo, BrazilWeb of ScienceLippincott Williams & WilkinsMax Delbruck Ctr Mol MedHannover Med SchUniversidade Federal de São Paulo (UNIFESP)Vanderbilt UnivHELIOS KlinGoncalves, Andrey C. da CostaTank, JensDiedrich, AndreHilzendeger, Aline Mourão [UNIFESP]Plehm, RalphBader, Michael [UNIFESP]Luft, Friedrich C.Jordan, JensGross, Volkmar2016-01-24T13:52:13Z2016-01-24T13:52:13Z2009-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion387-392http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.124776Hypertension. Philadelphia: Lippincott Williams & Wilkins, v. 53, n. 2, p. 387-392, 2009.10.1161/HYPERTENSIONAHA.108.1247760194-911Xhttp://repositorio.unifesp.br/handle/11600/31271WOS:000262625400045engHypertensioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2022-09-27T11:18:53Zoai:repositorio.unifesp.br/:11600/31271Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652022-09-27T11:18:53Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
title Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
spellingShingle Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
Goncalves, Andrey C. da Costa
type 2 diabetes mellitus
obesity
hypertension
ACE inhibition
alpha-2 adrenoceptors
autonomic dysfunction
title_short Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
title_full Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
title_fullStr Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
title_full_unstemmed Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
title_sort Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
author Goncalves, Andrey C. da Costa
author_facet Goncalves, Andrey C. da Costa
Tank, Jens
Diedrich, Andre
Hilzendeger, Aline Mourão [UNIFESP]
Plehm, Ralph
Bader, Michael [UNIFESP]
Luft, Friedrich C.
Jordan, Jens
Gross, Volkmar
author_role author
author2 Tank, Jens
Diedrich, Andre
Hilzendeger, Aline Mourão [UNIFESP]
Plehm, Ralph
Bader, Michael [UNIFESP]
Luft, Friedrich C.
Jordan, Jens
Gross, Volkmar
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Max Delbruck Ctr Mol Med
Hannover Med Sch
Universidade Federal de São Paulo (UNIFESP)
Vanderbilt Univ
HELIOS Klin
dc.contributor.author.fl_str_mv Goncalves, Andrey C. da Costa
Tank, Jens
Diedrich, Andre
Hilzendeger, Aline Mourão [UNIFESP]
Plehm, Ralph
Bader, Michael [UNIFESP]
Luft, Friedrich C.
Jordan, Jens
Gross, Volkmar
dc.subject.por.fl_str_mv type 2 diabetes mellitus
obesity
hypertension
ACE inhibition
alpha-2 adrenoceptors
autonomic dysfunction
topic type 2 diabetes mellitus
obesity
hypertension
ACE inhibition
alpha-2 adrenoceptors
autonomic dysfunction
description Leptin receptor-deficient db/db mice develop human type 2 diabetes mellitus, hypertension, and obesity with disrupted circadian blood pressure (BP) rhythm. Whether leptin is the sole mechanism mediating autonomic imbalance and hypertension is unclear. To explore this notion further, we measured BP by radiotelemetry combined with fast Fourier transformation and assessed autonomic function pharmacologically before and after renin-angiotensin system blockade with enalapril. the resting period BP (117 +/- 3 versus 108 +/- 1.0 mm Hg) and heart rate (HR; 488 +/- 12 versus 436 +/- 8 bpm) were higher in db/db mice compared with db/+ mice. BP and HR amplitudes were lower in db/db mice compared with db/+ mice. BP response to trimetaphan (-43 +/- 5 versus -27 +/- 3 mm Hg) and HR response to metoprolol (-59 +/- 12 versus -5 +/- 4 bpm) were greater in db/db mice than in db/+ mice. the HR response to atropine was blunted in db/db mice (59 +/- 17 versus 144 +/- 24 bpm), as were baroreflex sensitivity and HR variability. Enalapril improved autonomic regulation in db/db mice. Stimulation of central alpha-2 adrenoreceptors enhanced both parasympathetic HR control and baroreflex sensitivity in db/db mice. We suggest that functional, rather than structural, alpha-2 adrenoceptor changes and the renin-angiotensin system are involved in the increased sympathetic and decreased parasympathetic tones in db/db mice. Our data suggest that db/db mice exhibit features found in humans with type 2 diabetic autonomic neuropathy and could serve as a model for this complication. (Hypertension. 2009; 53[part 2]: 387-392.)
publishDate 2009
dc.date.none.fl_str_mv 2009-02-01
2016-01-24T13:52:13Z
2016-01-24T13:52:13Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.124776
Hypertension. Philadelphia: Lippincott Williams & Wilkins, v. 53, n. 2, p. 387-392, 2009.
10.1161/HYPERTENSIONAHA.108.124776
0194-911X
http://repositorio.unifesp.br/handle/11600/31271
WOS:000262625400045
url http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.124776
http://repositorio.unifesp.br/handle/11600/31271
identifier_str_mv Hypertension. Philadelphia: Lippincott Williams & Wilkins, v. 53, n. 2, p. 387-392, 2009.
10.1161/HYPERTENSIONAHA.108.124776
0194-911X
WOS:000262625400045
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Hypertension
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 387-392
dc.publisher.none.fl_str_mv Lippincott Williams & Wilkins
publisher.none.fl_str_mv Lippincott Williams & Wilkins
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268308683227136